ConductScience.org, home
HOXB13: homeobox B13
API referenceFor AI assistants

Gene · 10481

Papers1,917

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,917

Download this page as JSON
TitleJournalYearPMIDFound bySource
Breast Cancer Index and Recommendations for Extended Endocrine Therapy.JAMA Netw Open202642783373PubTator, text miningPubMed
Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications.Biochim Biophys Acta Rev Cancer202642637058PubTator, text miningPubMed
Correction to "Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma".
J Cell Commun Signal202642621181PubTator, text miningPubMed
Germline HOXB13 G84E Variant in a Patient with Gastric and Prostate Cancer: A Case Report and Literature Review.Case Rep Oncol202642578161PubTator, text miningPubMed
Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making.J Med Genet202642527158PubTator, text miningPubMed
Revisiting familial aggregation of prostate cancer within the 3D framework of genetics-epigenetics-environment.Mutat Res Rev Mutat Res202642492399PubTator, text miningPubMed
Miniaturized HOXB13 Mimetics Are Sequence-Specific, Methyl-Sensitive DNA Binders.J Am Chem Soc202642445955PubTator, text miningPubMed
HOXB13 Is a Sensitive and Specific Diagnostic Marker for Myxopapillary Ependymoma.Am J Surg Pathol202642444158PubTator, text miningPubMed
Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines.Eur J Breast Health202642317085PubTator, text miningPubMed
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.BJU Int202642265755PubTator, text miningPubMed
ML-driven quantum dots: novel HOXB13 imaging for porokeratosis with underlying squamous dysplasia associations.Ann Med Surg (Lond)202642254225PubTator, text miningPubMed
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.Mol Cancer Res202642189191PubTator, text miningPubMed
Imbalance in WNT: retinoic acid signaling dysregulates HOX gene expression: implications for cancer stem cell heterogeneity and CRC patient survival.Stem Cells Transl Med202642184974PubTator, text miningPubMed
HOXB13, a high-risk prostate cancer gene, also confers risk for breast cancer: novel variants of clinical significance, especially in hormone-positive patients.J Hum Genet202642174130PubTator, text miningPubMed
Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.J Obstet Gynaecol202642127212PubTator, text miningPubMed
Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma.J Cell Commun Signal202642100594PubTator, text miningPubMed
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.Clin Cancer Res202642012455PubTator, text miningPubMed
High-grade angiosarcoma arising beside a pelvic orthopedic implant: a case report.Int J Surg Case Rep202641938413PubTator, text miningPubMed
Chromatin accessibility regulates age-dependent nuclear mechanotransduction.Proc Natl Acad Sci U S A202641886372PubTator, text miningPubMed
Multicentre Evaluation of an AI-Assisted Urine Test for Clinically Significant Prostate Cancer in Men Undergoing Initial Biopsy.J Extracell Vesicles202641877634PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10481/papers

API referenceFor AI assistants